216 related articles for article (PubMed ID: 19874007)
1. Efficient site-specific radiolabeling of a modified C2A domain of synaptotagmin I with [99mTc(CO)3]+: a new radiopharmaceutical for imaging cell death.
Tavaré R; Torres Martin De Rosales R; Blower PJ; Mullen GE
Bioconjug Chem; 2009 Nov; 20(11):2071-81. PubMed ID: 19874007
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-labeled C2A domain of synaptotagmin I as a target-specific molecular probe for noninvasive imaging of acute myocardial infarction.
Zhao M; Zhu X; Ji S; Zhou J; Ozker KS; Fang W; Molthen RC; Hellman RS
J Nucl Med; 2006 Aug; 47(8):1367-74. PubMed ID: 16883018
[TBL] [Abstract][Full Text] [Related]
3. [Re(CO)(3)](+) labelling of a novel cysteine/hexahistidine tag: insights into binding mode by liquid chromatography-mass spectrometry.
Tavaré R; Williams J; Howland K; Blower PJ; Mullen GE
J Inorg Biochem; 2012 Sep; 114():24-7. PubMed ID: 22687562
[TBL] [Abstract][Full Text] [Related]
4. Recombinant complement receptor 2 radiolabeled with [99mTc(CO)3]+: a potential new radiopharmaceutical for imaging activated complement.
Badar A; DeFreitas S; McDonnell JM; Yahya N; Thakor D; Razavi R; Smith R; Sacks S; Mullen GE
PLoS One; 2011 Apr; 6(4):e18275. PubMed ID: 21494666
[TBL] [Abstract][Full Text] [Related]
5. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.
von Guggenberg E; Behe M; Behr TM; Saurer M; Seppi T; Decristoforo C
Bioconjug Chem; 2004; 15(4):864-71. PubMed ID: 15264875
[TBL] [Abstract][Full Text] [Related]
6. Copper-64 radiolabelling of the C2A domain of synaptotagmin I using a functionalised bis(thiosemicarbazone): A pre- and post-labelling comparison.
Hueting R; Tavaré R; Dilworth JR; Mullen GE
J Inorg Biochem; 2013 Nov; 128():108-11. PubMed ID: 23954480
[TBL] [Abstract][Full Text] [Related]
7. Extension of the single amino acid chelate concept (SAAC) to bifunctional biotin analogues for complexation of the M(CO)3(+1) Core (M = Tc and Re): syntheses, characterization, biotinidase stability, and avidin binding.
James S; Maresca KP; Allis DG; Valliant JF; Eckelman W; Babich JW; Zubieta J
Bioconjug Chem; 2006; 17(3):579-89. PubMed ID: 16704194
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the C2A domain of synaptotagmin-I and annexin-V as probes for detecting cell death.
Alam IS; Neves AA; Witney TH; Boren J; Brindle KM
Bioconjug Chem; 2010 May; 21(5):884-91. PubMed ID: 20402461
[TBL] [Abstract][Full Text] [Related]
9. Modification of low-density lipoprotein during radiolabeling with 99mTc using three labeling methods.
Sobal G; Resch U; Tatzber F; Sinzinger H
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):334-43. PubMed ID: 17043631
[TBL] [Abstract][Full Text] [Related]
10. [The radiolabeling property of oligonucleotide with 99mTc using NHS-MAG3 as a chelator].
Zhang C; Tan TZ; Kuang AR; Li YC; Zheng JG; Pan WM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):169-71. PubMed ID: 15071906
[TBL] [Abstract][Full Text] [Related]
11. [Technetium-99m labeled synaptotagmin I C2A detection of paclitaxel-induced apoptosis in non-small cell lung cancer].
Wang F; Fang W; Ji SD; Meng QL; Li Y; Fan KW; Wang ZZ
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):351-4. PubMed ID: 17892130
[TBL] [Abstract][Full Text] [Related]
12. Radiolabeling of annexin A5 with (99m)Tc: comparison of HYNIC-Tc vs. iminothiolane-Tc-tricarbonyl conjugates.
Biechlin ML; Bonmartin A; Gilly FN; Fraysse M; du Moulinet d'Hardemare A
Nucl Med Biol; 2008 Aug; 35(6):679-87. PubMed ID: 18678353
[TBL] [Abstract][Full Text] [Related]
13. Pyrazolyl derivatives as bifunctional chelators for labeling tumor-seeking peptides with the fac-[M(CO)3]+ moiety (M = 99mTc, Re): synthesis, characterization, and biological behavior.
Alves S; Paulo A; Correia JD; Gano L; Smith CJ; Hoffman TJ; Santos I
Bioconjug Chem; 2005; 16(2):438-49. PubMed ID: 15769099
[TBL] [Abstract][Full Text] [Related]
14. A critical quantum chemical and experimental study of the potentiality of direct labeling of the CN group with [(99m)Tc(CO)(3)](+) or [(186/188)Re(CO)(3)](+) in CN containing biomolecules.
Safi B; Mertens J; Kersemans K; Geerlings P
Nucl Med Biol; 2008 Oct; 35(7):747-53. PubMed ID: 18848659
[TBL] [Abstract][Full Text] [Related]
15. Membrane-bound orientation and position of the synaptotagmin C2B domain determined by site-directed spin labeling.
Rufener E; Frazier AA; Wieser CM; Hinderliter A; Cafiso DS
Biochemistry; 2005 Jan; 44(1):18-28. PubMed ID: 15628842
[TBL] [Abstract][Full Text] [Related]
16. Glucosamine conjugates bearing N,N,O-donors: potential imaging agents utilizing the [M(CO)3]+ core (M = Re, Tc).
Bowen ML; Lim NC; Ewart CB; Misri R; Ferreira CL; Häfeli U; Adam MJ; Orvig C
Dalton Trans; 2009 Nov; (42):9216-27. PubMed ID: 20449199
[TBL] [Abstract][Full Text] [Related]
17. Radiolabeling of fab and f(ab')2 antibody fragments with 99mTc(I) tricarbonyl core using a new bifunctional tridentate ligand.
Misri R; Saatchi K; Häfeli UO
Nucl Med Commun; 2011 Apr; 32(4):324-9. PubMed ID: 21285909
[TBL] [Abstract][Full Text] [Related]
18. Use of stabilized technetium-99m-exametazime for radiolabeling leukocytes.
Hung JC; Chowdhury S; Mullan BP
J Nucl Med; 1998 May; 39(5):912-7. PubMed ID: 9591600
[TBL] [Abstract][Full Text] [Related]
19. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides.
Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y
Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958
[TBL] [Abstract][Full Text] [Related]
20. Isostructural folate conjugates radiolabeled with the matched pair 99mTc/188Re: a potential strategy for diagnosis and therapy of folate receptor-positive tumors.
Müller C; Schubiger PA; Schibli R
Nucl Med Biol; 2007 Aug; 34(6):595-601. PubMed ID: 17707798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
